Beacon Therapeutics
David Fellows is the CEO of Beacon Therapeutics and the Chairman of Oxular. David also serves as the Board Chair at Terns Pharmaceuticals, a Board Member at Jaguar Gene Therapy and Gyroscope Therapeutics, and has previously held positions at Axovia Therapeutics and Arctos Optogenetics. Fellows is a former CEO of Nightstar Therapeutics and is a member of their Board of Directors. David attended Butler University from 1974 to 1978.
This person is not in any offices
Beacon Therapeutics
2 followers
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.